Global Parkinson's Disease Treatments Market Insights and Forecast to 2028

Report ID: 1565969 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dopamine Agonists
        1.2.3 Levodopa
        1.2.4 Glutamate Antagonist
        1.2.5 Apomorphine
        1.2.6 COMT Inhibitors Anticholinergics
        1.2.7 MAO-B Inhibitors
        1.2.8 Other Drugs
    1.3 Market by Application
        1.3.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Healthcare Institutes
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Parkinson's Disease Treatments Market Perspective (2017-2028)
    2.2 Parkinson's Disease Treatments Growth Trends by Region
        2.2.1 Parkinson's Disease Treatments Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Parkinson's Disease Treatments Historic Market Size by Region (2017-2022)
        2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Region (2023-2028)
    2.3 Parkinson's Disease Treatments Market Dynamics
        2.3.1 Parkinson's Disease Treatments Industry Trends
        2.3.2 Parkinson's Disease Treatments Market Drivers
        2.3.3 Parkinson's Disease Treatments Market Challenges
        2.3.4 Parkinson's Disease Treatments Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Parkinson's Disease Treatments Players by Revenue
        3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2017-2022)
        3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2017-2022)
    3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
    3.4 Global Parkinson's Disease Treatments Market Concentration Ratio
        3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2021
    3.5 Parkinson's Disease Treatments Key Players Head office and Area Served
    3.6 Key Players Parkinson's Disease Treatments Product Solution and Service
    3.7 Date of Enter into Parkinson's Disease Treatments Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Treatments Breakdown Data by Type
    4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2017-2022)
    4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2023-2028)
5 Parkinson's Disease Treatments Breakdown Data by Application
    5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2017-2022)
    5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Parkinson's Disease Treatments Market Size (2017-2028)
    6.2 North America Parkinson's Disease Treatments Market Size by Type
        6.2.1 North America Parkinson's Disease Treatments Market Size by Type (2017-2022)
        6.2.2 North America Parkinson's Disease Treatments Market Size by Type (2023-2028)
        6.2.3 North America Parkinson's Disease Treatments Market Share by Type (2017-2028)
    6.3 North America Parkinson's Disease Treatments Market Size by Application
        6.3.1 North America Parkinson's Disease Treatments Market Size by Application (2017-2022)
        6.3.2 North America Parkinson's Disease Treatments Market Size by Application (2023-2028)
        6.3.3 North America Parkinson's Disease Treatments Market Share by Application (2017-2028)
    6.4 North America Parkinson's Disease Treatments Market Size by Country
        6.4.1 North America Parkinson's Disease Treatments Market Size by Country (2017-2022)
        6.4.2 North America Parkinson's Disease Treatments Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Parkinson's Disease Treatments Market Size (2017-2028)
    7.2 Europe Parkinson's Disease Treatments Market Size by Type
        7.2.1 Europe Parkinson's Disease Treatments Market Size by Type (2017-2022)
        7.2.2 Europe Parkinson's Disease Treatments Market Size by Type (2023-2028)
        7.2.3 Europe Parkinson's Disease Treatments Market Share by Type (2017-2028)
    7.3 Europe Parkinson's Disease Treatments Market Size by Application
        7.3.1 Europe Parkinson's Disease Treatments Market Size by Application (2017-2022)
        7.3.2 Europe Parkinson's Disease Treatments Market Size by Application (2023-2028)
        7.3.3 Europe Parkinson's Disease Treatments Market Share by Application (2017-2028)
    7.4 Europe Parkinson's Disease Treatments Market Size by Country
        7.4.1 Europe Parkinson's Disease Treatments Market Size by Country (2017-2022)
        7.4.2 Europe Parkinson's Disease Treatments Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2017-2028)
    8.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type
        8.2.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Type (2017-2028)
    8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Application
        8.3.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Application (2017-2028)
    8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
        8.4.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Parkinson's Disease Treatments Market Size (2017-2028)
    9.2 Latin America Parkinson's Disease Treatments Market Size by Type
        9.2.1 Latin America Parkinson's Disease Treatments Market Size by Type (2017-2022)
        9.2.2 Latin America Parkinson's Disease Treatments Market Size by Type (2023-2028)
        9.2.3 Latin America Parkinson's Disease Treatments Market Share by Type (2017-2028)
    9.3 Latin America Parkinson's Disease Treatments Market Size by Application
        9.3.1 Latin America Parkinson's Disease Treatments Market Size by Application (2017-2022)
        9.3.2 Latin America Parkinson's Disease Treatments Market Size by Application (2023-2028)
        9.3.3 Latin America Parkinson's Disease Treatments Market Share by Application (2017-2028)
    9.4 Latin America Parkinson's Disease Treatments Market Size by Country
        9.4.1 Latin America Parkinson's Disease Treatments Market Size by Country (2017-2022)
        9.4.2 Latin America Parkinson's Disease Treatments Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2017-2028)
    10.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type
        10.2.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Type (2017-2028)
    10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application
        10.3.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Application (2017-2028)
    10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
        10.4.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 GSK Business Overview
        11.1.3 GSK Parkinson's Disease Treatments Introduction
        11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.1.5 GSK Recent Developments
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Parkinson's Disease Treatments Introduction
        11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.2.5 Merck Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Parkinson's Disease Treatments Introduction
        11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Teva
        11.4.1 Teva Company Details
        11.4.2 Teva Business Overview
        11.4.3 Teva Parkinson's Disease Treatments Introduction
        11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.4.5 Teva Recent Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
        11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Developments
    11.6 Impax
        11.6.1 Impax Company Details
        11.6.2 Impax Business Overview
        11.6.3 Impax Parkinson's Disease Treatments Introduction
        11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.6.5 Impax Recent Developments
    11.7 Abbvie
        11.7.1 Abbvie Company Details
        11.7.2 Abbvie Business Overview
        11.7.3 Abbvie Parkinson's Disease Treatments Introduction
        11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.7.5 Abbvie Recent Developments
    11.8 Bausch Health
        11.8.1 Bausch Health Company Details
        11.8.2 Bausch Health Business Overview
        11.8.3 Bausch Health Parkinson's Disease Treatments Introduction
        11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.8.5 Bausch Health Recent Developments
    11.9 Lundbeck
        11.9.1 Lundbeck Company Details
        11.9.2 Lundbeck Business Overview
        11.9.3 Lundbeck Parkinson's Disease Treatments Introduction
        11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.9.5 Lundbeck Recent Developments
    11.10 Sun Pharma
        11.10.1 Sun Pharma Company Details
        11.10.2 Sun Pharma Business Overview
        11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
        11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.10.5 Sun Pharma Recent Developments
    11.11 Wockhardt
        11.11.1 Wockhardt Company Details
        11.11.2 Wockhardt Business Overview
        11.11.3 Wockhardt Parkinson's Disease Treatments Introduction
        11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.11.5 Wockhardt Recent Developments
    11.12 Acadia
        11.12.1 Acadia Company Details
        11.12.2 Acadia Business Overview
        11.12.3 Acadia Parkinson's Disease Treatments Introduction
        11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.12.5 Acadia Recent Developments
    11.13 UCB
        11.13.1 UCB Company Details
        11.13.2 UCB Business Overview
        11.13.3 UCB Parkinson's Disease Treatments Introduction
        11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2017-2022)
        11.13.5 UCB Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Dopamine Agonists
    Table 3. Key Players of Levodopa
    Table 4. Key Players of Glutamate Antagonist
    Table 5. Key Players of Apomorphine
    Table 6. Key Players of COMT Inhibitors Anticholinergics
    Table 7. Key Players of MAO-B Inhibitors
    Table 8. Key Players of Other Drugs
    Table 9. Global Parkinson's Disease Treatments Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Parkinson's Disease Treatments Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Parkinson's Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Parkinson's Disease Treatments Market Share by Region (2017-2022)
    Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Parkinson's Disease Treatments Market Share by Region (2023-2028)
    Table 15. Parkinson's Disease Treatments Market Trends
    Table 16. Parkinson's Disease Treatments Market Drivers
    Table 17. Parkinson's Disease Treatments Market Challenges
    Table 18. Parkinson's Disease Treatments Market Restraints
    Table 19. Global Parkinson's Disease Treatments Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Parkinson's Disease Treatments Revenue Share by Players (2017-2022)
    Table 21. Global Top Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2021)
    Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Parkinson's Disease Treatments Product Solution and Service
    Table 26. Date of Enter into Parkinson's Disease Treatments Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2017-2022)
    Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2023-2028)
    Table 32. Global Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Parkinson's Disease Treatments Revenue Share by Application (2017-2022)
    Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Parkinson's Disease Treatments Revenue Share by Application (2023-2028)
    Table 36. North America Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Parkinson's Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Parkinson's Disease Treatments Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 66. GSK Company Details
    Table 67. GSK Business Overview
    Table 68. GSK Parkinson's Disease Treatments Product
    Table 69. GSK Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 70. GSK Recent Developments
    Table 71. Merck Company Details
    Table 72. Merck Business Overview
    Table 73. Merck Parkinson's Disease Treatments Product
    Table 74. Merck Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 75. Merck Recent Developments
    Table 76. Novartis Company Details
    Table 77. Novartis Business Overview
    Table 78. Novartis Parkinson's Disease Treatments Product
    Table 79. Novartis Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 80. Novartis Recent Developments
    Table 81. Teva Company Details
    Table 82. Teva Business Overview
    Table 83. Teva Parkinson's Disease Treatments Product
    Table 84. Teva Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 85. Teva Recent Developments
    Table 86. Boehringer Ingelheim Company Details
    Table 87. Boehringer Ingelheim Business Overview
    Table 88. Boehringer Ingelheim Parkinson's Disease Treatments Product
    Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 90. Boehringer Ingelheim Recent Developments
    Table 91. Impax Company Details
    Table 92. Impax Business Overview
    Table 93. Impax Parkinson's Disease Treatments Product
    Table 94. Impax Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 95. Impax Recent Developments
    Table 96. Abbvie Company Details
    Table 97. Abbvie Business Overview
    Table 98. Abbvie Parkinson's Disease Treatments Product
    Table 99. Abbvie Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 100. Abbvie Recent Developments
    Table 101. Bausch Health Company Details
    Table 102. Bausch Health Business Overview
    Table 103. Bausch Health Parkinson's Disease Treatments Product
    Table 104. Bausch Health Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 105. Bausch Health Recent Developments
    Table 106. Lundbeck Company Details
    Table 107. Lundbeck Business Overview
    Table 108. Lundbeck Parkinson's Disease Treatments Product
    Table 109. Lundbeck Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 110. Lundbeck Recent Developments
    Table 111. Sun Pharma Company Details
    Table 112. Sun Pharma Business Overview
    Table 113. Sun Pharma Parkinson's Disease Treatments Product
    Table 114. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 115. Sun Pharma Recent Developments
    Table 116. Wockhardt Company Details
    Table 117. Wockhardt Business Overview
    Table 118. Wockhardt Parkinson's Disease Treatments Product
    Table 119. Wockhardt Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 120. Wockhardt Recent Developments
    Table 121. Acadia Company Details
    Table 122. Acadia Business Overview
    Table 123. Acadia Parkinson's Disease Treatments Product
    Table 124. Acadia Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 125. Acadia Recent Developments
    Table 126. UCB Company Details
    Table 127. UCB Business Overview
    Table 128. UCB Parkinson's Disease Treatments Product
    Table 129. UCB Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 130. UCB Recent Developments
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson's Disease Treatments Market Share by Type: 2021 VS 2028
    Figure 2. Dopamine Agonists Features
    Figure 3. Levodopa Features
    Figure 4. Glutamate Antagonist Features
    Figure 5. Apomorphine Features
    Figure 6. COMT Inhibitors Anticholinergics Features
    Figure 7. MAO-B Inhibitors Features
    Figure 8. Other Drugs Features
    Figure 9. Global Parkinson's Disease Treatments Market Share by Application: 2021 VS 2028
    Figure 10. Hospitals Case Studies
    Figure 11. Healthcare Institutes Case Studies
    Figure 12. Others Case Studies
    Figure 13. Parkinson's Disease Treatments Report Years Considered
    Figure 14. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Parkinson's Disease Treatments Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Parkinson's Disease Treatments Market Share by Region: 2021 VS 2028
    Figure 17. Global Parkinson's Disease Treatments Market Share by Players in 2021
    Figure 18. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2021
    Figure 20. North America Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 22. North America Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 23. North America Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
    Figure 24. United States Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
    Figure 30. Germany Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Parkinson's Disease Treatments Market Size Share by Region (2017-2028)
    Figure 40. China Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
    Figure 50. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
    Figure 56. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 62. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 64. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 65. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 66. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 67. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 68. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 69. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 70. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 71. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB
Frequently Asked Questions
Parkinson's Disease Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson's Disease Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson's Disease Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Filling Binder

Filling Binder market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Methylmalonic Acid

Methylmalonic Acid market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More